ATOS Jan 2025 1.000 call
| Previous Close | 0.5100 |
| Open | 0.5100 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 1.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.5100 - 0.5100 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
ZacksAre Medical Stocks Lagging Alvotech (ALVO) This Year?
Here is how Alvotech (ALVO) and Atossa Genetics Inc. (ATOS) have performed compared to their sector so far this year.
GlobeNewswireAtossa Set to Join Russell 3000® Index Effective June 28, 2024
SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected upcoming inclusion in the Russell 3000® Index, according to preliminary Russell reconstruction information posted on the FTSE Russell website. The newly reconstructed index will take effect after the market closes on June 28, 2024. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical nee
ACCESSWIRESidoti Events, LLC's Virtual June Small-Cap Conference
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. ...
